INSULIN GLULISINE
INSULIN GLULISINE is a pharmaceutical drug with 60 clinical trials. Historical success rate of 91.2%.
Success Metrics
Based on 52 completed trials
Phase Distribution
Phase Distribution
10
Early Stage
5
Mid Stage
43
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
91.2%
52 of 57 finished
8.8%
5 ended early
0
trials recruiting
60
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
Clinical Trials (60)
The Impact of Two Different Insulin Dose Calculation on Postprandial Glycemia After Mixed Meal.
Super-Bolus: Effects on Postprandial Glycemia After High Glycemic Index Meal
The Effect of Insulin Glulisine Compared With Insulin Aspart on Breakfast Post Prandial Glucose Levels in Prepubertal Children
Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy
A Study to Demonstrate Bioequivalence Between Insulin Glulisine U300 and Insulin Glulisine U100 After a Single Subcutaneous Dose Using the Euglycemic Clamp Technique, in Patients With Type 1 Diabetes Mellitus
Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease
Investigation of the Safety of Intranasal Glulisine in Down Syndrome
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus
CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM)
Comparator Trial Using Insulin Glulisine vs. Insulin Lispro for Treatment of Gestational Diabetes
Normal Versus Dual Wave Insulin Bolus for High-protein Food
Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes
Insulin Requirement for Pure-protein Meal in Children With Type 1 Diabetes on Insulin Pumps.
Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents
Effect of LIXIsenatide on the Renal System
Safety and Effectiveness Study of Intranasal Insulin Glulisine on Cognitive and Memory in Mild-Mod AD Patients.
Diabetes in the Elderly: Prospective Study
Insulin Exposure and Glucose Response to Meals in Type 1 Diabetic Subjects Administered Two Different Insulin Regimens Compared to the Endogenous Insulin Exposure and Glucose Response to Meals In Healthy Adult Controls
Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus
Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Patients With Type 2 Diabetes Mellitus
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 60